comprehensive -WSS

comprehensive

author：explore 2025-08-26 23:46:11 - browse：1

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 4 killed in mass shooting in Georgia, shooter remains on the loose: Police

entertainment

focus

WSS

A new drug could help frostbite victims avoid its ravages

Federal judge rules Oregon’s tough new gun law is constitutional

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Surprise medical billing ban raises prices elsewhere

WATCH: Why do our ears pop?

Europe sees delivery challenges ahead on Alzheimer's therapies

focus

comprehensive

hotspot

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

BioMarin wins approval for gene therapy to treat hemophilia A

Obamacare plans could cover weight loss drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Surprise medical billing ban raises prices elsewhere

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Europe sees delivery challenges ahead on Alzheimer's therapies

Apple is now the first public company to be valued at $3 trillion

Weight loss drugs aren’t covered by Obamacare. That may change

Wikipedia

Can CDC director Mandy Cohen drive consensus in Washington?

Weight loss drugs aren’t covered by Obamacare. That may change

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Obamacare plans could cover weight loss drugs

Woman gored by Bison at Yellowstone

Researchers tackle phage therapy hurdles for wider adoption

entertainment

leisure time

focus

knowledge